These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 16926252

  • 21. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
    Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM.
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
    [Abstract] [Full Text] [Related]

  • 22. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [Abstract] [Full Text] [Related]

  • 23. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [Abstract] [Full Text] [Related]

  • 24. Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.
    Veldhuis JD, Keenan DM, Bailey JN, Adeniji A, Miles JM, Paulo R, Cosma M, Soares-Welch C.
    J Clin Endocrinol Metab; 2009 Jan; 94(1):246-54. PubMed ID: 18984660
    [Abstract] [Full Text] [Related]

  • 25. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
    [Abstract] [Full Text] [Related]

  • 26. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jørgensen JO.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [Abstract] [Full Text] [Related]

  • 27. Effects of transdermal testosterone gel or an aromatase inhibitor on serum concentration and pulsatility of growth hormone in older men with age-related low testosterone.
    Dias JP, Veldhuis JD, Carlson O, Shardell M, Chia CW, Melvin D, Egan JM, Basaria S.
    Metabolism; 2017 Apr; 69():143-147. PubMed ID: 28285644
    [Abstract] [Full Text] [Related]

  • 28. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 29. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.
    Christmas C, O'Connor KG, Harman SM, Tobin JD, Münzer T, Bellantoni MF, Clair CS, Pabst KM, Sorkin JD, Blackman MR.
    J Gerontol A Biol Sci Med Sci; 2002 Jan; 57(1):M12-8. PubMed ID: 11773207
    [Abstract] [Full Text] [Related]

  • 30. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
    [Abstract] [Full Text] [Related]

  • 31. Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency.
    Genazzani AR, Inglese S, Lombardi I, Pieri M, Bernardi F, Genazzani AD, Rovati L, Luisi M.
    Aging Male; 2004 Jun; 7(2):133-43. PubMed ID: 15672938
    [Abstract] [Full Text] [Related]

  • 32. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [Abstract] [Full Text] [Related]

  • 33. Aromatized Estrogens Amplify Nocturnal Growth Hormone Secretion in Testosterone-Replaced Older Hypogonadal Men.
    Roelfsema F, Yang RJ, Takahashi PY, Erickson D, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2018 Dec 01; 103(12):4419-4427. PubMed ID: 30032193
    [Abstract] [Full Text] [Related]

  • 34. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 1999 Jun 01; 84(6):2140-50. PubMed ID: 10372723
    [Abstract] [Full Text] [Related]

  • 35. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.
    Contemp Clin Trials; 2007 Feb 01; 28(2):153-68. PubMed ID: 16784898
    [Abstract] [Full Text] [Related]

  • 36. DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement.
    Aimaretti G, Baffoni C, Ambrosio MR, Maccario M, Corneli G, Bellone S, Gasperi M, Degli Uberti E, Ghigo E.
    J Endocrinol Invest; 2000 Jan 01; 23(1):5-11. PubMed ID: 10698044
    [Abstract] [Full Text] [Related]

  • 37. Correlation between the Aging Males' Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men.
    Miwa Y, Kaneda T, Yokoyama O.
    J Sex Med; 2006 Jul 01; 3(4):723-726. PubMed ID: 16839329
    [Abstract] [Full Text] [Related]

  • 38. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke KM, Kirschbaum C.
    J Clin Endocrinol Metab; 1997 Jul 01; 82(7):2363-7. PubMed ID: 9215320
    [Abstract] [Full Text] [Related]

  • 39. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
    Veldhuis JD, Bidlingmaier M, Anderson SM, Wu Z, Strasburger CJ.
    J Clin Endocrinol Metab; 2001 Jul 01; 86(7):3304-10. PubMed ID: 11443205
    [Abstract] [Full Text] [Related]

  • 40. Effects of growth hormone and/or sex steroid administration on whole-body protein turnover in healthy aged women and men.
    Huang X, Blackman MR, Herreman K, Pabst KM, Harman SM, Caballero B.
    Metabolism; 2005 Sep 01; 54(9):1162-7. PubMed ID: 16125527
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.